Beyond ganglion cells: Novel foveal avascular zone features in MS with implications for vision loss
超越神经节细胞:多发性硬化症中新的中心凹无血管区特征对视力丧失的影响
基本信息
- 批准号:10756395
- 负责人:
- 金额:$ 4.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAtrophicBiological MarkersBlindnessBrainCessation of lifeDetectionDiagnosisDiseaseElderlyExperimental ModelsEyeFunctional disorderGlaucomaImageImaging TechniquesLightLongitudinal StudiesMeasuresMinority GroupsMultiple SclerosisNeurodegenerative DisordersNeurologicOphthalmoscopyOptic NervePatientsPerimetryPersonsPhotoreceptorsPhysiciansPopulationProductivityProtocols documentationQuality of lifeResearchResearch PersonnelResolutionRetinaRetinal Ganglion CellsSample SizeScanningSiteSocietiesSpecificitySpinal CordStructureSymptomsTestingThinkingVisionVisualVisual PathwaysVisual impairmentWorkadaptive opticsclinical predictorscostganglion cellmiddle agemultiple sclerosis patientnervous system disordernovelretinal imaging
项目摘要
PROJECT SUMMARY
Multiple sclerosis (MS) is a devastating neuro-degenerative disease that causes visual impairment in young, middle aged
and older adults with resulting substantial lost productivity and cost to society. Current thinking attributes vision loss in
MS to death and dysfunction of the retinal ganglion cells (RGCs) that comprise the optic nerve. However, there is only
weak correlation between visual function and RGC atrophy, and some patients without RGC atrophy have vision loss,
suggesting that all relevant contributors to vision loss in MS have not been identified. We have discovered structural
features in the foveal avascular zone (FAZ) of retinas of the majority people with MS and a minority of people with
glaucoma that cast a shadow on the photoreceptor layer and correlate with visual function. Our discovery contributes to
addressing gaps in understanding visual pathway involvement in MS, offering new windows into diagnosis and treatment
of vision loss in MS. This project studies the recently discovered FAZ features in retinas of people with MS and related
diseases using adaptive optics scanning light ophthalmoscopy, a high resolution, non-invasive, state-of-the-art imaging
technique. In the first aim, the relationship between central visual function and FAZ features will be defined using MS as
an experimental model. Advanced microperimetry will be used to test the hypothesis that photoreceptor shadowing is
the mechanism of vision loss. In the second aim the cause and composition of the FAZ features will be inferred through
longitudinal studies of people with MS, cross sectional comparison between MS, glaucoma and related neurological and
ophthalmic diseases and histopathological study of ex-vivo MS eyes. In the third aim rapid imaging protocols will be
developed to enable faster detection of FAZ features and these will be applied to estimate the distributions of FAZ features
in the populations with MS, glaucoma, other diseases and controls. These observations will evaluate the candidacy of the
FAZ features as biomarkers of MS by defining specificity. The immediate impact of this research will be advancing
understanding of vision loss in MS, developing rapid imaging strategies to enable broader study of large sample sizes at
multiple sites and evaluating FAZ features as biomarkers in MS, glaucoma and other disease.
项目概要
多发性硬化症 (MS) 是一种毁灭性的神经退行性疾病,会导致年轻、中年人视力障碍
和老年人,从而导致生产力严重损失和社会成本。目前的想法将视力丧失归因于
MS 导致构成视神经的视网膜神经节细胞 (RGC) 死亡和功能障碍。然而,只有
视功能与RGC萎缩的相关性较弱,部分无RGC萎缩的患者出现视力下降,
这表明尚未确定导致多发性硬化症视力丧失的所有相关因素。我们发现了结构性
大多数多发性硬化症患者和少数多发性硬化症患者视网膜中央凹无血管区 (FAZ) 的特征
青光眼在感光层上投射阴影并与视觉功能相关。我们的发现有助于
弥补对多发性硬化症视觉通路参与理解的差距,为诊断和治疗提供新的窗口
MS 中的视力丧失。该项目研究最近发现的多发性硬化症及相关患者视网膜中的 FAZ 特征
使用自适应光学扫描光检眼镜检查疾病,这是一种高分辨率、非侵入性、最先进的成像技术
技术。在第一个目标中,中央视觉功能和 FAZ 特征之间的关系将使用 MS 定义为
一个实验模型。先进的显微视野测量法将用于检验光感受器阴影的假设
视力丧失的机制。在第二个目标中,FAZ 特征的原因和组成将通过以下方式推断:
对多发性硬化症患者的纵向研究,多发性硬化症、青光眼及相关神经系统和疾病之间的横断面比较
眼科疾病和离体多发性硬化症眼的组织病理学研究。在第三个目标中,快速成像协议将是
开发用于更快地检测 FAZ 特征,这些将用于估计 FAZ 特征的分布
患有多发性硬化症、青光眼、其他疾病和控制的人群。这些观察结果将评估候选人的候选资格
FAZ 通过定义特异性而成为 MS 的生物标志物。这项研究的直接影响将不断推进
了解 MS 中的视力丧失,开发快速成像策略,以便能够对大样本量进行更广泛的研究
多个位点并评估 FAZ 特征作为多发性硬化症、青光眼和其他疾病的生物标志物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Heather Elspeth Moss其他文献
Heather Elspeth Moss的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Heather Elspeth Moss', 18)}}的其他基金
Beyond ganglion cells: Novel foveal avascular zone features in MS with implications for vision loss
超越神经节细胞:多发性硬化症中新的中心凹无血管区特征对视力丧失的影响
- 批准号:
10707139 - 财政年份:2022
- 资助金额:
$ 4.46万 - 项目类别:
Beyond ganglion cells: Novel foveal avascular zone features in MS with implications for vision loss
超越神经节细胞:多发性硬化症中新的中心凹无血管区特征对视力丧失的影响
- 批准号:
10522605 - 财政年份:2022
- 资助金额:
$ 4.46万 - 项目类别:
Beyond ganglion cells: Novel foveal avascular zone features in MS with implications for vision loss
超越神经节细胞:多发性硬化症中新的中心凹无血管区特征对视力丧失的影响
- 批准号:
10522605 - 财政年份:2022
- 资助金额:
$ 4.46万 - 项目类别:
Retinal vessel features as a marker of idiopathic intracranial hypertension treatment response: a secondary analysis of the idiopathic intracranial hypertension treatment trial
视网膜血管特征作为特发性颅内高压治疗反应的标志:特发性颅内高压治疗试验的二次分析
- 批准号:
10043677 - 财政年份:2020
- 资助金额:
$ 4.46万 - 项目类别:
Retinal vessel features as a marker of idiopathic intracranial hypertension treatment response: a secondary analysis of the idiopathic intracranial hypertension treatment trial
视网膜血管特征作为特发性颅内高压治疗反应的标志:特发性颅内高压治疗试验的二次分析
- 批准号:
10043677 - 财政年份:2020
- 资助金额:
$ 4.46万 - 项目类别:
Retinal vessel features as a marker of idiopathic intracranial hypertension treatment response: a secondary analysis of the idiopathic intracranial hypertension treatment trial
视网膜血管特征作为特发性颅内高压治疗反应的标志:特发性颅内高压治疗试验的二次分析
- 批准号:
10223317 - 财政年份:2020
- 资助金额:
$ 4.46万 - 项目类别:
Physiologically Based Markers of Idiopathic Intracranial Hypertension
特发性颅内高压的生理标志物
- 批准号:
9262224 - 财政年份:2016
- 资助金额:
$ 4.46万 - 项目类别:
Physiologically Based Markers of Idiopathic Intracranial Hypertension
特发性颅内高压的生理标志物
- 批准号:
9343081 - 财政年份:2016
- 资助金额:
$ 4.46万 - 项目类别:
Physiologically Based Markers of Idiopathic Intracranial Hypertension
特发性颅内高压的生理标志物
- 批准号:
9457463 - 财政年份:2016
- 资助金额:
$ 4.46万 - 项目类别:
Physiologically Based Markers of Idiopathic Intracranial Hypertension
特发性颅内高压的生理标志物
- 批准号:
8827356 - 财政年份:2014
- 资助金额:
$ 4.46万 - 项目类别:
相似国自然基金
基于lncRNA NONHSAT042241/hnRNP D/β-catenin轴探讨雷公藤衍生物(LLDT-8)对类风湿关节炎滑膜成纤维细胞功能影响及机制研究
- 批准号:82304988
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
针刺手法和参数对针刺效应启动的影响及其机制
- 批准号:82305416
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
二仙汤影响肾上腺皮质-髓质激素分泌及调控下丘脑温度感受器以缓解“天癸竭”潮热的研究
- 批准号:82374307
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
固定翼海空跨域航行器出水稳定性与流体动力载荷影响机制
- 批准号:52371327
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
经济制裁对跨国企业海外研发网络建构的影响:基于被制裁企业的视角
- 批准号:72302155
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Pathogenic T cells in discoid lupus erythematosus
盘状红斑狼疮中的致病性 T 细胞
- 批准号:
10664134 - 财政年份:2023
- 资助金额:
$ 4.46万 - 项目类别:
Individualized Profiles of Sensorineural Hearing Loss from Non-Invasive Biomarkers of Peripheral Pathology
周围病理学非侵入性生物标志物的感音神经性听力损失个体化概况
- 批准号:
10827155 - 财政年份:2023
- 资助金额:
$ 4.46万 - 项目类别:
Mentoring Emerging Researchers at CHLA (MERCH-LA)
指导 CHLA (MERCH-LA) 的新兴研究人员
- 批准号:
10797938 - 财政年份:2023
- 资助金额:
$ 4.46万 - 项目类别:
Plasma neurofilament light chain as a potential disease monitoring biomarker in Wolfram syndrome
血浆神经丝轻链作为 Wolfram 综合征潜在疾病监测生物标志物
- 批准号:
10727328 - 财政年份:2023
- 资助金额:
$ 4.46万 - 项目类别:
Interactions Between the Microbiota and Helicobacter pylori in Gastric Carcinogenesis
微生物群与幽门螺杆菌在胃癌发生中的相互作用
- 批准号:
10709135 - 财政年份:2023
- 资助金额:
$ 4.46万 - 项目类别: